Attend
Read
Watch
Listen
About Us
Work with Us
Events
Contact
Weekly Digest
Job Board
synbiobeta 2021
live
OCTOBER 4 - 6
May 23-25
Oakland Marriott, California
Learn More
Because Being In The Same Room Is Better Than Being On The Same Zoom!
@ the Oakland Marriott City Center, Oakland CA
Back
Contact
What Is Synthetic Biology?
About BWB
Our Staff
Our Writers
Back
Contact
Advertise
Sponsors
Exhibitors
Conflict of Interest
Back
Contact
Job Board
Back
Contact
Current Event
Conferences
Courses
Industry Tours
Attend
Read
Watch
Listen
Weekly Digest
Site Search
Close
Become a Member
Insider
Free
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Insider Premium
$3/month
Access to Premium Articles
Pick your content preferences
Industry Insider Newsletter
Invitation to Panel
Signup
Read
OUR LATEST DIGESTS
August 9, 2022
$280b CHIPS+Science, $84m for Jenny Rooke’s Genoa + biodesign with DALL·E.
Sponsored by:
July 25, 2022
Ginkgo Bioworks to Acquire Zymergen for $300M
Sponsored by:
July 20, 2022
Video: Is neurotech the next stage in human evolution? MycoWorks launches fashion items, Manifold Bio raises $40M
Sponsored by:
See More Digests »
Click Here to Subscribe
to Our Weekly Digest
SYNBIOBETA
SPOTLIGHTS
Lumen Bio
The human immune system is very good at recognizing foreign proteins. While this is critical for protecting against infections, it is sometimes too good: protein therapeutics like monoclonal antibodies are typically much safer than small molecule drugs, but the body often rejects them as foreign. Meet Lumen Bioscience, an antibody engineering company delivering therapeutics to places where our bodies won’t reject them: the GI tract, nasal passages, and skin. Our immune system is accustomed to all the foreign proteins we eat, smell, and touch, so this improves safety. These antibody drugs can be delivered in higher concentrations which improves efficacy against certain diseases. Learn more about Lumen’s promising clinical trial results and how they can produce antibodies at one-hundredth of the cost!
Cambrium
Consider the origins of the products we use in our daily lives; almost everything owes its history to the oil field, the strip mine or the slaughterhouse. Meet Cambrium, a Berlin-based synthetic biology company rethinking the material world by designing sustainable, high-impact proteins and producing them with microbes! By engineering the amino acid sequence in structural proteins, the company creates novel materials with specific properties and functions. Starting with optimized collagen for cosmetics, Cambrium is building a pipeline of highly functional, animal-free, fossil-free ingredients to usher in a new materials future without compromise. Learn more about Cambrium’s first product launch and stay tuned for news of the company’s upcoming collaborations with innovators in skincare and beyond!
SQIM
It’s no secret that animal agriculture is severely damaging our planet. While we transition our diets to sustainable proteins, we also need to reimagine our materials, especially leather. Meet SQIM, a materials company bringing plastic-free "mycelium leather" to market! By leveraging liquid and solid-state fermentation, SQIM is quickly scaling the production of EPHEA, a novel class of superior materials that can be thoroughly customized for use in the fashion industry. EPHEA can be dyed, embossed, finished, and adapted to create animal-free, high-quality products, without harming our planet. Learn more about SQIM, the ongoing scale-up of EPHEA, and their commercially available mycelium-based products for interior design, MOGU! (image: EPHEA)
LUCA
Women’s health has been long overlooked and underserved. Non-prescription supplements often claim to help women’s vaginal microbiome health, but none of them have proven therapeutic value. Meet LUCA Biologics, a biotechnology company developing a new class of microbe-based therapies to treat unmet needs in women's health. The company’s living medicines, which target the vaginal microbiome for urogenital and reproductive health, will go through a full FDA approval process and could finally offer women solutions for antibiotic-resistant UTIs, STIs, bacterial vaginosis and preterm birth. LUCA is also working to support women’s health globally, not only in affluent regions. Learn more about LUCA’s goals of supporting women and keep up with their clinical trial progress!
Molecular Devices & IDT
Collaboration, collaboration, collaboration: that’s the name of the synbio game and that’s why Molecular Devices and IDT are teaming up to make it easier for biotech companies to accelerate their research. For 35 years, IDT has supplied DNA constructs that are critical for research and discovery. Molecular Devices focuses on automated hardware and software for upstream and downstream processing and the robotics needed to screen up to 30,000 DNA clones every day. The companies’ synergy is clear: IDT supplies custom DNA and Molecular Devices provides the tools to efficiently run experiments and analyze the results. Now the companies are taking their synergy a step further. Learn more about IDT and Molecular Devices’ 2022 special offer to accelerate companies operating in the bioeconomy!
Roswell Biotechnologies
Most people wait to feel sick before they go to the doctor. But imagine if you could wake up in the morning, do a quick scan of your health using a semiconductor chip and immediately know your health status before symptoms even start. This kind of technology could democratize healthcare and ensure everyone can access their health information quickly and reliably. Meet Roswell Biotechnologies, a company turning individual molecules into biosensors on a chip. By miniaturizing biosensors, Roswell is able to fully leverage the power of chip technology to create scalable, affordable data snapshots about our health and our environment. Learn more about how Roswell is deploying their technology in drug discovery, biosecurity, crop protection, and much more!
See More Spotlights »
INDUSTRY NEWS
Filter by Category
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Policy & Public
Food & Nutrition
Entrepreneurship
Energy & Environment
Emerging Technologies
Consumer Goods
Biomanufacturing, Chemicals & Materials
Funding & Investments
Health & Medicine
Agriculture
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
August 16, 2022
Ginkgo Bioworks and XpresCheck Receive Award to Expand CDC's Traveler-Based SARS-CoV-2 Genomic Surveillance Program In U.S. Airports
August 16, 2022
Ginkgo Bioworks and the Rwanda Development Board Announce Plans to Develop and Implement New Biosecurity Capabilities in Rwanda
August 16, 2022
Synlogic Announces Synthetic Biotic for Gout Developed in Partnership with Ginkgo Bioworks
August 16, 2022
Bluestem Biosciences, a Sustainable Chemicals Startup, Closes $5 Million Pre-Seed Funding to Scale Discovery Through Industrial Anaerobic Fermentation
August 9, 2022
Codexis and Molecular Assemblies Announce Execution of Commercial License and Enzyme Supply Agreement for Optimized TdT Enzyme for Enzymatic DNA Synthesis
August 3, 2022
Artisan Launches STAR-CRISPR™ to Provide Broad Gene Editing Access for Drug Discovery and Development
August 3, 2022
Genoa Ventures Announces Second Fund to Expand Investing in the Convergence of Biology and Technology
August 2, 2022
Berkeley Lights and Aanika BioSciences Reach Strategic Partnership Milestone By Identifying A Commercially Viable Antimicrobial Peptide
July 29, 2022
Insempra Announces Strategic Investment in Solena Materials
July 27, 2022
Ginkgo and Bayer Sign Definitive Agreement to Build Agricultural Biologicals R&D Platform Capabilities
July 27, 2022
TetraScience Launches Revolutionary Scientific Data Cloud, Unlocking Innovation and Value Throughout R&D, Manufacturing, and Quality Control
July 25, 2022
MycoWorks Commercializes Reishi™, the World's First Plastic-Free, Mycelium Leather Alternative, with Luxury Hatmaker Nick Fouquet
July 18, 2022
Ginkgo Bioworks Announces Latest Collaboration for Beauty and Personal Care Industry with Sumitomo Chemical
July 18, 2022
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform
July 16, 2022
Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls
July 15, 2022
Allonnia Discovers New PFAS Biosensor
July 15, 2022
Spiderwort secures $13.2M USD in Series A Financing to Accelerate Clinical Trials of Revolutionary Biomaterials
July 13, 2022
Synlogic Initiates Phase 1 Study of SYNB1353 for the Treatment of Homocystinuria (HCU)
July 13, 2022
String Bio-Woodside Energy Collaboration for Sustainable Manufacturing
July 13, 2022
Epic Bio, Founded by CRISPR Pioneer, Launches to Revolutionize Genetic Medicine With Epigenetic Engineering
July 12, 2022
Next
1 / 159